Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
350.40
+9.30 (2.73%)
Aug 14, 2025, 4:59 PM CET

Zealand Pharma Revenue

Zealand Pharma had revenue of 9.09B DKK in the quarter ending June 30, 2025, with 26,527.65% growth. This brings the company's revenue in the last twelve months to 9.11B, up 2,375.69% year-over-year. In the year 2024, Zealand Pharma had annual revenue of 62.69M, down -81.71%.

Revenue (ttm)
9.11B
Revenue Growth
+2,375.69%
P/S Ratio
2.66
Revenue / Employee
23.66M
Employees
335
Market Cap
24.21B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202462.69M-280.10M-81.71%
Dec 31, 2023342.79M238.80M229.65%
Dec 31, 2022103.99M-4.56M-4.20%
Dec 31, 2021108.55M-83.46M-43.47%
Dec 31, 2020192.00M150.67M364.52%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Novo Nordisk 311.94B
Coloplast 27.79B
Genmab 23.16B
Demant 22.42B
ALK-Abelló 5.71B
H. Lundbeck 22.95B
Ambu A/S 5.83B
Bavarian Nordic 6.23B
Revenue Rankings